-
TraceLink Launches Digital Supply Chain Solutions
contractpharma
April 20, 2020
Pharma supply chain solutions provider TraceLink has introduced a new package of agile solutions designed to digitalize the pharmaceutical supply chain.
-
ABL Supports Fill/Finish of COVID-19 Vaccine Candidate
contractpharma
April 20, 2020
Utilizes its aseptic fill/finish facility to support confidential clients' COVID-19 vaccine development.
-
Eagle Pharma’s Drug Shows Antiviral Activity Against COVID-19
contractpharma
April 20, 2020
IND submitted to FDA for clinical study at Hackensack University Medical Center to evaluate Ryanodex for treatment of COVID-19 patients.
-
HALIX Enters COVID-19 Tie-up with University of Oxford
contractpharma
April 20, 2020
Alliance for the scale-up of a GMP manufacturing process and production of a coronavirus vaccine.
-
CirrusDx Receives Emergency Use Authorization for COVID-19 Testing
americanpharmaceuticalreview
April 20, 2020
Cirrus Dx received Emergency Use Authorization (EUA) from the US Food & Drug Administration (FDA) to perform SARS-COVID-19 testing.
-
FDA Announces Temporary Policy for Compounding Drugs for Hospitalized Patients
americanpharmaceuticalreview
April 20, 2020
The Food and Drug Administration (FDA) plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic.
-
Production of Avigan® Tablet (favipiravir) accelerated for use against COVID-19
europeanpharmaceuticalreview
April 20, 2020
FUJIFILM intends to accelerate production of Avigan to 100,000 treatment courses per month by July and up to 300,000 by September 2020 to meet demand for possible use treating COVID-19.
-
Open letter calls for UK government to stop pharma profiting from COVID-19
europeanpharmaceuticalreview
April 20, 2020
An open letter from aid organisations and academics has called on the UK government to stipulate conditions for pharmaceutical companies using public funding for COVID-19 vaccines.
-
Novo Nordisk offers free 90-day insulin supply to patients due to COVID-19
europeanpharmaceuticalreview
April 20, 2020
Novo Nordisk has set up a programme to allow patients in the US experiencing financial hardship because of COVID-19 to receive free insulin for 90 days.
-
University of Waterloo to develop nasal vaccine for Covid-19
pharmaceutical-technology
April 20, 2020
University of Waterloo researchers in Canada are developing a DNA-based vaccine candidate that can be given via nasal route to protect from Covid-19 infection.